Analysis of biallelic inactivation of the von Hippel-Lindau tumor suppressor gene VHL in patients of renal cell carcinoma patient.
- Author:
Ning LIU
1
;
Kan GONG
;
Ning ZHANG
;
Hong-feng GUO
;
Xi NA
;
Guan WU
;
Yan-qun NA
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Carcinoma, Renal Cell; genetics; pathology; Chromosomes, Human, Pair 3; genetics; DNA Mutational Analysis; Female; Genes, Tumor Suppressor; Humans; Kidney Neoplasms; genetics; pathology; Loss of Heterozygosity; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Tumor Suppressor Proteins; genetics; Ubiquitin-Protein Ligases; genetics; Von Hippel-Lindau Tumor Suppressor Protein
- From: Chinese Journal of Surgery 2005;43(2):115-117
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate biallelic inactivation of the von Hippel-Lindau tumor suppressor gene (VHL) in patient of renal cell carcinoma (RCC) patient.
METHODSWe extracted tumor and normal DNA from 41 RCC patients. Mutation of VHL gene from tumor tissue was detected from tumor tissue by polymerase chain reaction (PCR) and direct sequencing. Two single nucleotide polymorphism (SNP) sites located in VHL gene were analyzed by PCR restriction fragment length polymorphism, and loss of heterozygosity (LOH) was analyzed for VHL gene by comparing between tumor with normal tissue.
RESULTSMutation and LOH of VHL gene was found in 51% (21/41) and 42% (8/19) of RCC patients respectively. LOH was highly associated with mutation positive tumors (r = 0.78) and VHL biallelic inactivation was detected in 37% of RCC patients.
CONCLUSIONBiallelic inactivation of VHL gene occurs in RCC due to VHL mutation and LOH, and its frequency rate is 37%.
